Benchmark started Abbott Laboratories with a Buy rating and a $145 price target, calling the diversified healthcare company a steady performer in a volatile global environment.

To check your blood sugar levels at home, you can use a glucose meter or a continuous glucose monitor. Here's what you should know about both devices.

Abbott Laboratories' said on Monday it had received clearance to market the smallest version of its fastest-growing low-cost diabetes monitoring product in the European Union.

Studies indicate sliding scale insulin therapy is ineffective at managing blood sugar and can be too strict for most people.

Zahi Fayad is leading a Digital Twins study investigating how our health data can be put to better use to help us live ...

The researchers found that in those without diabetes, continuous glucose monitors are not a substitute for HbA1c. HealthDay News — Continuous glucose monitors (CGMs) do not accurately reflect blood ...

Continuous glucose monitors (CGMs) are wearable devices that track blood sugar levels in real time. They are helpful for ...

Abbott Laboratories recently received Health Canada approval for the Esprit BTK Everolimus Eluting Resorbable Scaffold System ...

Medshield Medical Scheme launched its benefit options and contributions for 2026, building on its Partner for Life offering ...

The FDA has granted de novo classification to the Biolinq Shine wearable biosensor, which would be the first needle-free CGM ...

Here's how Android 17's new "Medical" profile will streamline setup and improve reliability for medical devices.

Insulet’s chief growth officer said: “colour has the power to differentiate a brand,” with mango orange adorning Omnipod’s ...